The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium

[1]  J. Danesh,et al.  Genetically determined height and coronary artery disease. , 2015, The New England journal of medicine.

[2]  G. Davey Smith,et al.  Mendelian randomization: genetic anchors for causal inference in epidemiological studies , 2014, Human molecular genetics.

[3]  Eric J Tchetgen Tchetgen,et al.  Methodological Challenges in Mendelian Randomization , 2014, Epidemiology.

[4]  S. Burgess.  Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome , 2014, International journal of epidemiology.

[5]  Terho Lehtimäki,et al.  Lipoprotein subclass profiling reveals pleiotropy in the genetic variants of lipid risk factors for coronary heart disease: a note on Mendelian randomization studies. , 2013, Journal of the American College of Cardiology.

[6]  Sarah E. Medland,et al.  Mining the Human Phenome Using Allelic Scores That Index Biological Intermediates , 2013, PLoS genetics.

[7]  S. Thompson,et al.  Use of allele scores as instrumental variables for Mendelian randomization , 2013, International journal of epidemiology.

[8]  T. Edwards,et al.  Pleiotropy between Genetic Markers of Obesity and Risk of Prostate Cancer , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[9]  G. Colditz,et al.  Prostate cancer: is it time to expand the research focus to early-life exposures? , 2013, Nature Reviews Cancer.

[10]  D. Barocas,et al.  Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer--evidence of effect modification by prostate size. , 2013, Cancer letters.

[11]  D. Lawlor,et al.  Child height, health and human capital: Evidence using genetic markers , 2013, European economic review.

[12]  Peter Kraft,et al.  Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array , 2013, Nature Genetics.

[13]  Carol Propper,et al.  The effect of fat mass on educational attainment: Examining the sensitivity to different identification strategies , 2012, Economics and human biology.

[14]  K. W. Davidson,et al.  Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. , 2012, International journal of epidemiology.

[15]  A. Price,et al.  Dietary fatty acid intake and prostate cancer survival in Örebro County, Sweden. , 2012, American journal of epidemiology.

[16]  A. Wolk,et al.  Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  George Davey Smith,et al.  Using multiple genetic variants as instrumental variables for modifiable risk factors , 2012, Statistical methods in medical research.

[18]  N. Timpson,et al.  The Effect of Elevated Body Mass Index on Ischemic Heart Disease Risk: Causal Estimates from a Mendelian Randomisation Approach , 2012, PLoS medicine.

[19]  Jenny Donovan,et al.  Circulating insulin-like growth factors and IGF-binding proteins in PSA-detected prostate cancer: the large case-control study ProtecT. , 2012, Cancer research.

[20]  F. Hamdy,et al.  Serum insulin-like growth factors and mortality in localised and advanced clinically detected prostate cancer , 2011, Cancer Causes & Control.

[21]  A. Wolk,et al.  Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: a population-based prospective study , 2011, British Journal of Cancer.

[22]  Yin Cao,et al.  Body Mass Index, Prostate Cancer–Specific Mortality, and Biochemical Recurrence: a Systematic Review and Meta-analysis , 2011, Cancer Prevention Research.

[23]  G. Smith.  Use of genetic markers and gene-diet interactions for interrogating population-level causal influences of diet on health , 2011, Genes & Nutrition.

[24]  F. Hamdy,et al.  Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies. , 2010, European journal of cancer.

[25]  Jenny Donovan,et al.  Associations between an Obesity Related Genetic Variant (FTO rs9939609) and Prostate Cancer Risk , 2010, PloS one.

[26]  Ayellet V. Segrè,et al.  Hundreds of variants clustered in genomic loci and biological pathways affect human height , 2010, Nature.

[27]  F. Hamdy,et al.  The relation between adiposity throughout the life course and variation in IGFs and IGFBPs: evidence from the ProtecT (Prostate testing for cancer and Treatment) study , 2010, Cancer Causes & Control.

[28]  Tanya M. Teslovich,et al.  Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index , 2010 .

[29]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[30]  Associations of lower urinary tract symptoms with prostate‐specific antigen levels, and screen‐detected localized and advanced prostate cancer: a case‐control study nested within the UK population‐based ProtecT (Prostate testing for cancer and Treatment) study , 2008, BJU international.

[31]  Ross J. Harris,et al.  Height and Prostate Cancer Risk: A Large Nested Case-Control Study (ProtecT) and Meta-analysis , 2008, Cancer Epidemiology Biomarkers & Prevention.

[32]  Elaine A. Ostrander,et al.  Multiple Novel Prostate Cancer Predisposition Loci Confirmed by an International Study: The PRACTICAL Consortium , 2008, Cancer Epidemiology Biomarkers & Prevention.

[33]  S. Freedland,et al.  Obesity and prostate cancer: epidemiology and clinical implications. , 2007, European urology.

[34]  N. Sheehan,et al.  Mendelian randomization as an instrumental variable approach to causal inference , 2007, Statistical methods in medical research.

[35]  A. Kristal,et al.  Anthropometrics and prostate cancer risk. , 2007, American journal of epidemiology.

[36]  E. Platz,et al.  Obesity and prostate cancer: making sense out of apparently conflicting data. , 2007, Epidemiologic reviews.

[37]  Dallas R. English,et al.  Body size and composition and prostate cancer risk: systematic review and meta-regression analysis , 2006, Cancer Causes & Control.

[38]  I. Thompson,et al.  Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial , 2006, Cancer Epidemiology Biomarkers & Prevention.

[39]  A. Chokkalingam,et al.  Prostate cancer epidemiology. , 2006, Frontiers in bioscience : a journal and virtual library.

[40]  T. Peters,et al.  Do height-related variations in insulin-like growth factors underlie the associations of stature with adult chronic disease? , 2004, The Journal of clinical endocrinology and metabolism.

[41]  R. Hayes,et al.  Cancer Causes & Control , 2004, Cancer Causes & Control.

[42]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[43]  R. Hayes,et al.  Height and the survival of prostate cancer patients. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[44]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.

[45]  Douglas G Altman,et al.  Interaction revisited: the difference between two estimates , 2003, BMJ : British Medical Journal.

[46]  D. Gunnell.  Can adult anthropometry be used as a 'biomarker' for prenatal and childhood exposures? , 2002, International journal of epidemiology.

[47]  M. Thun,et al.  Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[48]  R. Cooper,et al.  Height and risk of fatal prostate cancer: findings from the National Health Interview Survey (1986 to 1994). , 2001, Annals of epidemiology.

[49]  D. Gunnell,et al.  Height, leg length, and cancer risk: a systematic review. , 2001, Epidemiologic reviews.

[50]  T. Peters,et al.  Socio-economic and dietary influences on leg length and trunk length in childhood: a reanalysis of the Carnegie (Boyd Orr) survey of diet and health in prewar Britain (1937-39). , 1998, Paediatric and perinatal epidemiology.

[51]  E. Rimm,et al.  Height, body weight, and risk of prostate cancer. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.